COCP - コクリスタル・ファ―マ (Cocrystal Pharma Inc.)

COCPのニュース

   Sabby Management, Llc Buys Cocrystal Pharma Inc, Enochian BioSciences Inc, Aterian Inc, Sells ...  2021/08/18 16:38:36 GuruFocus
Related Stocks: ATOS , RIOT , MOGO , IONS , AMRN , HMCO , COCP , ENOB , ATER , RCON , VINC , GLBS , PENN , VTSI , 5UQ , XELA , XBI , AUPH ,
   Stock with Negative, Positive Change: Li Auto Inc. (NASDAQ:LI), Cocrystal Pharma, Inc. (NASDAQ:COCP)  2021/08/17 21:19:24 Stock Equity
Li Auto Inc. (NASDAQ:LI) with the stream of 0.47% also noticed, India Cocrystal Pharma, Inc. (NASDAQ:COCP) encountered a rapid change of -2.97% in the last hour of Tuesdays trading session. The post Stock with Negative, Positive Change: Li Auto Inc. (NASDAQ:LI), Cocrystal Pharma, Inc. (NASDAQ:COCP) appeared first on Stocks Equity .
   Stock Buzzers: Cocrystal Pharma, Inc. (NASDAQ:COCP), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)  2021/08/17 01:19:45 Stock Equity
Cocrystal Pharma, Inc. (COCP) with the stream of -4.73% also noticed, India AcelRx Pharmaceuticals, Inc. (ACRX) encountered a rapid change of -4.27% in the last hour of Mondays trading session. The post Stock Buzzers: Cocrystal Pharma, Inc. (NASDAQ:COCP), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) appeared first on Stocks Equity .
   Cocrystal Pharma Reports Second Quarter 2021 Financial Results and Provides Antiviral Program and Milestone Updates  2021/08/16 12:00:00 Cocrystal Pharma
   Attention Seeking Stock: Itau Unibanco Holding S.A. (NYSE:ITUB), Cocrystal Pharma, Inc. (NASDAQ:COCP)  2021/08/12 00:35:57 Stock Equity
Itau Unibanco Holding S.A. (NYSE:ITUB) with the stream of 0.43% also noticed, India Cocrystal Pharma, Inc. (NASDAQ:COCP) encountered a rapid change of 0.94% in the last hour of Wednesdays trading The post Attention Seeking Stock: Itau Unibanco Holding S.A. (NYSE:ITUB), Cocrystal Pharma, Inc. (NASDAQ:COCP) appeared first on Stocks Equity .
   Cocrystal Pharma added to Russell Microcap Index  2021/06/28 13:28:10 Seeking Alpha
   Cocrystal Joins Russell Microcap® Index  2021/06/28 12:00:00 Intrado Digital Media
BOTHELL, Wash., June 28, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, coronaviruses, hepatitis C viruses and noroviruses, announces that it will be added to the Russell Microcap ® Index after the U.S. market opens today, June 28, 2021.
   Cocrystal Joins Russell Microcap Index  2021/06/28 12:00:00 Wallstreet:Online
BOTHELL, Wash., June 28, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, coronaviruses, hepatitis C viruses and noroviruses, announces that it will be added to the Russell Microcap Index after
   Cocrystal Pharma plans to initiate a phase 1 trial of CC-42344 in Q3 2021  2021/06/23 12:13:41 Seeking Alpha
   Cocrystal Pharma Completes IND-enabling Studies with CC-42344 for the Treatment of Seasonal and Pandemic Influenza A, Plans to initiate a Phase 1 Trial in the Third Quarter  2021/06/23 12:00:00 Intrado Digital Media
BOTHELL, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (Cocrystal or the Company), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, coronaviruses, hepatitis C viruses and noroviruses, announces the completion of IND-enabling studies with its potent, broad-spectrum PB2 inhibitor CC-42344 for the treatment of seasonal and pandemic influenza A and plans to initiate Phase 1 clinical development of CC-42344 in the third quarter of 2021.

calendar